Healthcare provider profile · identity verified

Hillary Cohen Ecker, MD

Internal Medicine · MORTON GROVE, IL · NPI 1356601256

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	474	159
Levothyroxine Sodium	Levothyroxine Sodium	256	74
Lisinopril	Lisinopril	251	83
Amlodipine Besylate	Amlodipine Besylate	241	84
Losartan Potassium	Losartan Potassium	187	61
Metformin Hcl	Metformin Hcl	174	56
Metoprolol Succinate	Metoprolol Succinate	139	46
Simvastatin	Simvastatin	133	40
Omeprazole	Omeprazole	128	43
Gabapentin	Gabapentin	113	40
Sertraline Hcl	Sertraline Hcl	94	30
Alprazolam	Alprazolam	88	26
Hydrochlorothiazide	Hydrochlorothiazide	82	26
Rosuvastatin Calcium	Rosuvastatin Calcium	80	25
Montelukast Sodium	Montelukast Sodium	77	27
Metformin Hcl Er	Metformin Hcl	74	26
Pantoprazole Sodium	Pantoprazole Sodium	73	31
Alendronate Sodium	Alendronate Sodium	69	24
Pravastatin Sodium	Pravastatin Sodium	66	16
Tramadol Hcl	Tramadol Hcl	55	13
Escitalopram Oxalate	Escitalopram Oxalate	54	20
Furosemide	Furosemide	54	20
Albuterol Sulfate Hfa	Albuterol Sulfate	53	24
Tamsulosin Hcl	Tamsulosin Hcl	53	20
Glimepiride	Glimepiride	51	19
Fluticasone Propionate	Fluticasone Propionate	48	21
Trazodone Hcl	Trazodone Hcl	47	19
Ozempic	Semaglutide	41	12
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Januvia	Sitagliptin Phosphate	36	11
Triamcinolone Acetonide	Triamcinolone Acetonide	36	21
Bupropion Xl	Bupropion Hcl	35	11
Famotidine	Famotidine	35	13
Metoprolol Tartrate	Metoprolol Tartrate	35	12
Carvedilol	Carvedilol	34	14
Jardiance	Empagliflozin	34	15
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Synthroid	Levothyroxine Sodium	28	12
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	11
Atenolol	Atenolol	23	suppressed
Eliquis	Apixaban	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Finasteride	Finasteride	18	suppressed
Prednisone	Prednisone	18	12
Fenofibrate	Fenofibrate	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Valsartan	Valsartan	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error